论文部分内容阅读
应用APACHEⅡ评分对我院SICU1991年5月~1995年9月间连续的普外危重病182例严重度进行评估。用死亡率预测方程(MPM)判定预后,结果显示平均APACHEⅡ评分18.22±5.6分,预测病死率和实际病死率呈正相关(31.3%vs34.6%,γ=0.98),预测略低于实际(P>0.05)。27例肝功能障碍者平均积分为20.8±4.6分,预测病死率显著低于实际(37.5%vs70.4%,P<0.001)。为APACHEⅡ预测意义的主要影响因素。入院时APACHEⅡ<15分均存活,>28分均死亡,15~28分的共72例,通过连续评分,于第5天或第25天死亡组和存活组病人APACHEⅡ出现显著性差异,有助于预后判断。监护技术的进步,会使病死率不断下降,APACHEⅡ可作为评价SICU救治水平的标尺。
Application of APACHE Ⅱ score on our hospital SICU May 1991 ~ September 1995 continuous serious generalized critical illness in 182 cases were evaluated. The prognosis was estimated by the mortality prediction equation (MPM). The mean APACHEⅡ score was 18.22 ± 5.6 and the predicted mortality was positively correlated with the actual mortality (31.3% vs 34.6%, γ = 0.98) , Slightly lower than the actual forecast (P> 0.05). The average score of 27 patients with liver dysfunction was 20.8 ± 4.6, the predicted mortality was significantly lower than the actual (37.5% vs 70.4%, P <0.001). The main influencing factors for APACHE Ⅱ prediction. APACHE Ⅱ <15 points survived at admission, died> 28 points, and 72 cases at 15-28 points. There was significant difference in APACHEⅡ between death group and survivor group on the 5th or 25th day by continuous score Judgment of prognosis. Monitoring technology advances, will make the case fatality rate decline, APACHE Ⅱ can be used as a measure of the level of SICU treatment.